Literature DB >> 10150860

Therapeutic rationale for normal-tension glaucoma.

R A Hitchings1.   

Abstract

Three problems exist when assessing the effectiveness of treatment for normal-tension glaucoma. Firstly, it is a common type of primary open-angle glaucoma. Secondly, the extent to which it is a pressure-sensitive disease remains to be seen. Thirdly, it is possible that normal-tension glaucoma is a collection of different disease entities. This review will look at the therapeutic options available for treatment and divide them into these which attempt to moderate IOP, and those which attempt to alter blood flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10150860     DOI: 10.1097/00055735-199504000-00011

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  6 in total

Review 1.  Normal tension glaucoma--a practical approach.

Authors:  D Kamal; R Hitchings
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

2.  The influence of the calcium channel blocker verapamil on experimental glaucoma.

Authors:  Irina N Mikheytseva; Ludmila T Kashintseva; George N Krizhanovsky; Olga P Kopp; Elena M Lipovetskaya
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

3.  Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma.

Authors:  Fabian Anders; Julia Teister; Aiwei Liu; Sebastian Funke; Franz H Grus; Solon Thanos; Harald D von Pein; Norbert Pfeiffer; Verena Prokosch
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

4.  Ocular Pressure-Volume Relationship and Ganglion Cell Death in Glaucoma.

Authors:  Ji-Jie Pang; Samuel M Wu
Journal:  OBM Neurobiol       Date:  2021-05-20

5.  Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.

Authors:  Verena Prokosch; Maurice Schallenberg; Solon Thanos
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

6.  Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model.

Authors:  Maurice Schallenberg; Verena Prokosch; Solon Thanos
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.